Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy

At the Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego, the epidemiology department advances research on cardiovascular diseases by evaluating new therapeutic approaches and assessing their impact on clinical outcomes.

• Heart failure with preserved or reduced ejection fraction
• Hypertrophic cardiomyopathy and atrial fibrillation
• Coronary artery disease and atherosclerotic risk
• Hypertension, including resistant forms
• Arrhythmogenic and dilated cardiomyopathies
• Acute myocardial infarction and post‑event risk reduction

The initiative leverages extensive patient registries to uncover risk patterns and fosters multicenter collaborations throughout Europe.

Research at the institute focuses on nutritional and metabolic diseases, seeking to improve prevention strategies and evaluate therapies that address obesity, diabetes, and related metabolic disorders.

• Obesity and overweight in individuals with cardiovascular risk
• Prediabetes management in patients with coronary artery disease
• Type 2 diabetes treatment with emerging agents
• Hyperlipidemia and lipoprotein(a) lowering interventions
• Uric acid metabolism and its cardiovascular implications

By integrating metabolic profiling, the program aims to identify early biomarkers and support lifestyle‑focused interventions alongside pharmacologic options.

The epidemiology unit also investigates respiratory tract diseases, emphasizing the interplay between breathing disorders and heart health while testing novel diagnostic and therapeutic measures.

• Obstructive sleep apnea in overweight adults
• Pulmonary hypertension secondary to heart failure with preserved ejection fraction
• Impact of chronic respiratory conditions on cardiovascular outcomes

Collaborative efforts with pulmonology specialists enable comprehensive assessments and the development of integrated care pathways for affected patients.